Document ID: chunk:federal_register_of_legislation:F2020L01425:reg:5
Version: federal_register_of_legislation:F2020L01425
Segment Type: reg
Provision Reference: reg 5
Character Range: 2507–3186

5  Prescribed program
 (1) For the purposes of subsection 33(1) of the Act, the Thermochemical Conversion Technology Trial Facility Program (the program) is prescribed.
 (2) The program provides funding to ARI Global Technologies Australasia Pty Ltd for the purpose of assisting it to carry out steps preliminary to the construction and operation of a thermochemical conversion technology trial facility for the disposal of asbestos waste, including by:
 (a) undertaking planning and risk assessment; and
 (b) identifying and assessing possible sites for the facility; and
 (c) acquiring a site for the facility; and
 (d) obtaining regulatory approvals to operate the facility.